Literature DB >> 18390485

Congenital pseudarthrosis of the tibia.

Kelly L Vander Have1, Robert N Hensinger, Michelle Caird, Charles Johnston, Frances A Farley.   

Abstract

Congenital pseudarthrosis of the tibia is characterized by anterolateral deformity of the tibia and shortening of the limb. Its etiology remains unclear. Although several classification systems have been proposed, none provides specific guidelines for management. Treatment remains challenging. The goal is to obtain and maintain union while minimizing deformity. The basic biologic considerations with surgical intervention include resection of the pseudarthrosis and bridging of the defect with stable fixation. Intramedullary stabilization, free vascularized fibula, and Ilizarov external fixation are among the most frequently used methods of treatment. In addition, bone morphogenetic protein recently has shown promise. Nevertheless, despite improvements in healing rates with congenital pseudarthrosis of the tibia, the potential for amputation in failed cases persists.

Entities:  

Mesh:

Year:  2008        PMID: 18390485     DOI: 10.5435/00124635-200804000-00006

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  12 in total

1.  Congenital pseudoarthrosis tibia with fibrous hamartoma in a child with neurofibromatosis.

Authors:  Meenu Pujani; Neha Kawatra Madan; Shailaja Shukla
Journal:  J Lab Physicians       Date:  2013-01

Review 2.  Ilizarov treatment of congenital pseudarthrosis of the tibia: a multi-targeted approach using the Ilizarov technique.

Authors:  In Ho Choi; Tae-Joon Cho; Hyuk Ju Moon
Journal:  Clin Orthop Surg       Date:  2011-02-15

3.  BMP7-overexpressing bone marrow-derived mesenchymal stem cells (BMSCs) are more effective than wild-type BMSCs in healing fractures.

Authors:  Xu Yan; Zhenhua Zhou; Lixin Guo; Zhaochi Zeng; Zhongkai Guo; Qingdong Shao; Weidong Xu
Journal:  Exp Ther Med       Date:  2018-06-21       Impact factor: 2.447

Review 4.  Anterolateral Tibial Bowing and Congenital Pseudoarthrosis of the Tibia: Current Concept Review and Future Directions.

Authors:  Matthew J Siebert; Christopher A Makarewich
Journal:  Curr Rev Musculoskelet Med       Date:  2022-07-16

5.  Functional and radiological outcomes after treatment of congenital pseudarthrosis of the tibia using the Ilizarov technique: a retrospective single-center study.

Authors:  Ahmed Ibrahim Zayda; Mohamed Kamal Mesregah; Soliman Hassan Zalalo; Samy Abdel-Hady Sakr
Journal:  J Orthop Traumatol       Date:  2022-09-23

6.  Diagnostic and treatment challenge in adult presentation of congenital pseudoarthrosis of the tibia: A case report.

Authors:  Faisal Miraj; Dina Aprilya
Journal:  Ann Med Surg (Lond)       Date:  2020-08-29

7.  Management of congenital pseudarthrosis of the tibia with the Ilizarov method in a paediatric population: influence of aetiological factors.

Authors:  Dmitry Y Borzunov; Alexander Y Chevardin; Alexander I Mitrofanov
Journal:  Int Orthop       Date:  2015-11-07       Impact factor: 3.075

Review 8.  Prevalence of neurofibromatosis type 1 in congenital pseudarthrosis of the tibia.

Authors:  Kjell Van Royen; Hilde Brems; Eric Legius; Johan Lammens; Armand Laumen
Journal:  Eur J Pediatr       Date:  2016-08-12       Impact factor: 3.183

9.  Burnei's procedure in the treatment of long bone pseudarthrosis in patients having osteogenesis imperfecta or congenital pseudarthrosis of tibia - preliminary report.

Authors:  C Vlad; I Georgescu; T S Gavriliu; D I Hodorogea; T El Nayef; D Dan
Journal:  J Med Life       Date:  2012-06-18

10.  Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) for the Treatment of Nonunion of the Femur in Children and Adolescents: A Retrospective Analysis.

Authors:  Tim N Hissnauer; Norbert Stiel; Kornelia Babin; Martin Rupprecht; Karsten Ridderbusch; Johannes M Rueger; Ralf Stuecker; Alexander S Spiro
Journal:  Biomed Res Int       Date:  2017-03-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.